View of Trends and Cost Effectiveness of Allogeneic Stem Cell Transplant in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy.

Return to Article Details Trends and Cost Effectiveness of Allogeneic Stem Cell Transplant in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy. Download Download PDF